This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Meyer, H A M. Articles by Seed, P. T Search for Related Content PubMed PubMed Citation Articles by Meyer, H A M. Articles by Seed, P. T Social Bookmarking                         What's this?

Depressive symptoms in advanced cancer. Part 1. Assessing depression: the Mood Evaluation Questionnaire

Claire Sinnott

Department of Palliative Medicine, St Thomas' Hospital, London

Paul T Seed

Department of Public Health Sciences, Guy's, King's and St Thomas' School of Medicine, King's College London, London

Objective: A prospective cohort study evaluated the performance and acceptability of the cognitive based Mood Evaluation Questionnaire (MEQ) in assessing depressive symptoms over time in patients with advanced cancer. The structured clinical interview for DSM-III-R (SCID) and the single-item interview screening question were also administered.

Method: Forty-five advanced cancer patients were followed monthly for up to six interviews (108 interviews in total).

Results: The MEQ and SCID had moderate agreement (weighted kappa 0.52 over all interviews). At first interview, 26 (58%) patients were depressed using MEQ, seven (16%) of these severely. Attrition rates were high for subsequent interviews. The assessment process was considered positive by 92% patients, and acceptable as a single and repeat measure. Positive responses to MEQ questions about worthlessness, death and self-harm were strong predictors of current depressed mood.

Conclusion: The MEQ has potential as a useful alternative to SCID in assessing depressive symptoms in a palliative care population, and can be used by nonpsychiatric trained professionals. It is positively received by patients and acceptable as a repeat measure. Most patients appreciate being asked about their mood in depth, including questions around death and self harm.

Key Words: cancer • depression assessment • palliative care • prevalence • scale • validation

Palliative Medicine, Vol. 17, No. 7, 596-603 (2003)
DOI: 10.1191/0269216303pm812oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A. Vodermaier, W. Linden, and C. Siu Screening for Emotional Distress in Cancer Patients: A Systematic Review of Assessment Instruments J Natl Cancer Inst, November 4, 2009; 101(21): 1464 - 1488. [Abstract] [Full Text] [PDF]

				C. W. Jackson and K. H. Jackson Comorbid Depression in Adult Oncology Journal of Pharmacy Practice, October 1, 2007; 20(5): 360 - 367. [Abstract] [PDF]

				S.C.C.M. Teunissen, A. de Graeff, E.E. Voest, and J.C.J.M. de Haes Are anxiety and depressed mood related to physical symptom burden? A study in hospitalized advanced cancer patients Palliative Medicine, June 1, 2007; 21(4): 341 - 346. [Abstract] [PDF]

				J. A Robinson and G. B Crawford Identifying palliative care patients with symptoms of depression: an algorithm Palliative Medicine, June 1, 2005; 19(4): 278 - 287. [Abstract] [PDF]